Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis

Inclusion Criteria: * Age: Participants must be between 18 and 70 years of age. * HBsAg Positive: Participants must be positive for hepatitis B surface antigen (HBsAg). * Confirmed Hepatocellular Carcinoma (HCC): Participants must have a pathological confirmation of HCC via surgical resection or local ablation. * BCLC Staging: Participants must have a Barcelona Clinic Liver Cancer (BCLC) staging of 0 or A. * Liver Function: Participants must have normal or well-compensated liver function, classified as Child-Pugh A. * Expected Survival: Participants must have an expected survival of more than 3 months. * Informed Consent: Participants must sign an informed consent form and agree to comply with the study requirements. If a participant is unable to sign the consent form, a legal guardian or agent must do so. Exclusion Criteria: * Prior Systemic Cancer Treatments: Participants who have received prior systemic cancer treatments such as liver transplantation, chemotherapy, targeted therapy, or biological therapy will be excluded. * Other Active Malignancies: Participants with a history or presence of other active malignancies, except for skin basal cell carcinoma or squamous cell carcinoma that has been cured, or cervical carcinoma in situ, will be excluded. * Allergies to Interferon: Participants who are allergic to interferon or any of its components, or whom the investigator deems unsuitable for interferon therapy, will be excluded. * Other Chronic Liver Diseases: Participan…